Poster Presentation Nutrition Society of Australia 50th Annual Scientific Meeting 2026

Effect of GLP-1 agonist semaglutide on macronutrient preference and plasma FGF21 levels (147036)

Guoliang Deng 1 2 , Amanda E Brandon 1 2 , Mahvash A Goolam 1 2 , Flora Mackay 1 2 , Carsten Schmitz-Peiffer 1 2 , David Raubenheimer 1 2 , Stephen J Simpson 1 2 , Arthur D Conigrave 1 2 3
  1. Charles Perkins Centre, University of Sydney, Camperdown, NSW, Australia
  2. School of Life and Environmental Sciences, University of Sydney, Camperdown, NSW, Australia
  3. Department of Endocrinology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia
Publish consent withheld
  1. Solon-Biet, et al (2023). Cell reports, 42(12).
  2. Huang, Y., et al (2026). Ebiomedicine, 124.
  3. Emptage, I., et al (2026). eClinicalMedicine.
  4. Feng, J. N., et al (2023). Physiological Reports, 11(5), e15620.